The hospital costs of treating necrotizing fasciitis

Abstract

This study has confirmed that a significant economic burden is involved in treating necrotizing fasciitis. There is a substantial difference between the hospital costs and government funding for treating these patients in the Australian setting.

Human Immunodeficiency Virus Infection Associated with Necrotizing Fasciitis: A Cohort Study of Texas Population, 2001-2010

“…Use of ICU was mentioned in 4 patients described in prior case reports of HIVassociated NF [7,8,11,13]. Our findings are similar to those reported by Widjaja et al [27] and Das et al [24], showing need for ICU care in 63% and 56% of their patients, respectively. Nevertheless, critical care utilization patterns vary across countries [29) and regionally [30], limiting a direct comparison.…”

“…Indeed the small number of HIV-associated NF hospitalizations, even at a population-level examination over a 10-year period, has limited our trend analyses and overall estimates of patient, resource, and outcome attributes. In addition, the morbidity burden of HIV-associated NF in the present study, as judged by rate of ICU admission and hospital length of stay, is comparable to reports on NF in the general population [2,24,27,31]. On the other hand, we cannot exclude underestimation of HIV-associated NF in our cohort.…”

“…As noted earlier, clinical details other than those pertaining to NF were commonly limited in prior descriptions of patients with HIV-associated NF. Other sites of infection were reported in the general population with NF in 30% [26] to 76% [27] of patients.…”

Necrotizing Soft-Tissue Infections: Clinical Guidelines

“…6 Hospital costs can be a major burden, with mean costs reported from $60,000 to $115,000 in data from 2001 to 2004. 7,8 Patients with NSTI are often treated at facilities with burn centers for their complex wound management and critical care issues, 1,2 but it has been difficult to show any mortality benefit at burn centers because of variations in severity of NSTI treated at different institutions. 8 The most common risk factor for development of NSTI is diabetes mellitus, with as many as 56% of patients having diabetes in one large series.…”

Impacto de Dos Métodos Alternativos de Asignación de Costos Indirectos Estructurales de Hospitales Públicos Chilenos en el Costo Final de Producción de Servicios Sanitarios

“…La determinació n de los costos de servicios sanitarios brindados por hospitales no solamente tiene trascendencia para su gestió n financiera, sino tambié n para comparar dos o má s alternativas de servicios hospitalarios y establecer cuá l de ellas es má s conveniente desde el punto de vista econó mico [1][2][3][4][5][6][7][8][9][10].…”